Recombinant Human B4GALNT2 Protein Summary
Recombinant Protein
B4GALNT2
Applications/Dilutions
62.3 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Packaging, Storage & Formulations
Store at -80C. Avoid freeze-thaw cycles.
25 mM Tris-HCl of pH8.0 containing 2% glycerol.
No Preservative
Notes
This product is produced by and distributed for Abnova, a company based in Taiwan.
Alternate Names for Recombinant Human B4GALNT2 Protein
- 4 GalNAcT/Sda-GalNAcT
- B4GALT
- beta 1,4 N-acetylgalactosaminyltransferase/betal
- beta-1,4 N-acetylgalactosaminyltransferase 2
- beta-1,4-N-acetyl-galactosaminyl transferase 2
- beta-4-N-acetylgalactosaminyltransferase
- GALGT2
- MGC142235
- MGC142237
- sd(a) beta-1,4-GalNAc transferase
- sda beta-1,4-GalNAc transferase
- UDP-GalNAc:Neu5Aca2-3Galb-R b1,4-N-acetylgalactosaminyltransferase
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.
product targets : Gli inhibitors